Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Astrocytes Play Key Role in Memory Storage and Recall, Study Shows

Astrocytes Play Key Role in Memory Storage and Recall, Study Shows

A New Statistical Method to Mitigate AI Bias in Genetic Research

A New Statistical Method to Mitigate AI Bias in Genetic Research

APOE4 and Microglia Together Drive Alzheimer's Protein Deposits

APOE4 and Microglia Together Drive Alzheimer's Protein Deposits

Novel Approach to Isolating and Quantifying EV Cargo for Disease Diagnosis

Novel Approach to Isolating and Quantifying EV Cargo for Disease Diagnosis

Necroptosis Emerges as a Key Target in Alzheimer's Disease

Necroptosis Emerges as a Key Target in Alzheimer's Disease

Personalized Mini-Brains Provide Insight into Autism Spectrum Disorder

Personalized Mini-Brains Provide Insight into Autism Spectrum Disorder

A Novel Regulator of RNA Processing in Alzheimer's Disease

A Novel Regulator of RNA Processing in Alzheimer's Disease

A New Technique Reveals the Behavior of OPCs in the Brain

A New Technique Reveals the Behavior of OPCs in the Brain

Two Alzheimer’s Genetic Risk Factors Trigger Harmful Inflammation in Females

Two Alzheimer’s Genetic Risk Factors Trigger Harmful Inflammation in Females

Potassium Isotope Ratios: A Potential Biomarker for Early Alzheimer's Disease Diagnosis

Potassium Isotope Ratios: A Potential Biomarker for Early Alzheimer's Disease Diagnosis

Single-Cell RNA Sequencing Reveals Cellular Changes in Early Alzheimer's Disease

Single-Cell RNA Sequencing Reveals Cellular Changes in Early Alzheimer's Disease

Mitochondrial DNA 'Jumps' to Chromosomes, Potentially Impacting Lifespan

Mitochondrial DNA 'Jumps' to Chromosomes, Potentially Impacting Lifespan

Revealing Neural Basis of Categorizing and Remembering Novel Information

Revealing Neural Basis of Categorizing and Remembering Novel Information

Single-Cell Analysis Uncovers Impact of TREM2 Mutation on Beta-Amyloid Plaques

Single-Cell Analysis Uncovers Impact of TREM2 Mutation on Beta-Amyloid Plaques

Breakthrough Method Captures Aging Impact on Alzheimer’s Disease in Lab-Grown Neurons

Breakthrough Method Captures Aging Impact on Alzheimer’s Disease in Lab-Grown Neurons

Breakthrough in Understanding Brain's Master Protein

Breakthrough in Understanding Brain's Master Protein

Study Challenges Current Understanding of Parkinson's and Lewy Body Disease Onset

Study Challenges Current Understanding of Parkinson's and Lewy Body Disease Onset

Rapid Parkinson's Model Opens Door to Personalized Treatments

Rapid Parkinson's Model Opens Door to Personalized Treatments

Traffic-Related Ultrafine Particles Cause Mitochondrial Dysfunction in Olfactory Mucosa

Traffic-Related Ultrafine Particles Cause Mitochondrial Dysfunction in Olfactory Mucosa

Oligodendrocytes as Producers of Amyloid Beta in Alzheimer's Disease

Oligodendrocytes as Producers of Amyloid Beta in Alzheimer's Disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.